Aniracetam Capsules

This product has the effect of improving memory impairment and can counteract memory loss caused by hypoxia. The average oral elimination half-life is 22 minutes. It has a fast onset of action, strong effect and low toxicity. It is used for mental and behavioral disorders after cerebrovascular disease, and can improve living ability and memory. It has no sedative effect.

Aniracetam.

This product is a capsule, and the contents are off-white granules and powder.

1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in the middle-aged and elderly.

Take orally 0.2g once, 3 times a day, for 1 to 2 months. The safe range is 0.3g to 1.8g a day.

Adverse reactions may include dry mouth, loss of appetite, constipation, dizziness, and drowsiness, which disappear after stopping the drug. Occasionally, there are reports of excitement, restlessness, and systemic rash.

Patients who are allergic to this product or cannot tolerate other pyrrolidone drugs are prohibited from using this product.

Precautions for children: No such experiment has been conducted and no reliable references are available. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Use the usual dose.

Not yet clear.

Keep sealed, valid for 24 months.

0.1 g

48 months

Wuxi Cathy Pharmaceuticals Ltd.

• Founded in:

  2002-09-13

• Address:

  Wuxi New District 75-B Plot

• Tax NO.:

  91320214743143547B

• Registered Funds:

  $3.75 million

• Email:

  Log in to view